Vir Biotechnology Inc (VIR) — Financial Flexibility Index
Vir Biotechnology Inc (VIR) has a Financial Flexibility Index of -0.62x as of March 2026. Free cash flow of $-132.00 Million (operating CF $-132.39 Million minus capex $390.00K) represents -1% of total liabilities ($212.82 Million). Check asset allocation strategy of Vir Biotechnology Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vir Biotechnology Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Vir Biotechnology Inc across 9 annual periods. See Vir Biotechnology Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vir Biotechnology Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Vir Biotechnology Inc. For the full company profile including market capitalisation, see Vir Biotechnology Inc (VIR) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.63x | $-386.95 Million | $-391.78 Million | $237.55 Million | ▲ +7.8% |
| 2024 | -1.77x | $-439.05 Million | $-446.35 Million | $248.43 Million | ▲ +23.3% |
| 2023 | -2.30x | $-757.21 Million | $-778.78 Million | $328.82 Million | ▼ -196.3% |
| 2022 | 2.39x | $1.73 Billion | $1.66 Billion | $724.12 Million | ▲ +4946.4% |
| 2021 | -0.05x | $-25.77 Million | $-47.59 Million | $522.42 Million | ▲ +94.6% |
| 2020 | -0.91x | $-184.39 Million | $-190.94 Million | $201.91 Million | ▲ +33.3% |
| 2019 | -1.37x | $-120.69 Million | $-129.63 Million | $88.13 Million | ▼ -491.1% |
| 2018 | -0.23x | $-85.90 Million | $-94.10 Million | $370.77 Million | ▼ -16.7% |
| 2017 | -0.20x | $-63.64 Million | $-66.38 Million | $320.48 Million | — |